Skip to main content
user-generated· regulatory

Merck cancer vaccine FDA filing by Q3 2027

Market overview

Merck submits cancer vaccine to FDA for approval within the next three quarters.

regulatory prediction market

Implied probability (Yes)
68%
Closes
2027-05-31

More regulatory markets

Browse all regulatory markets →

Loading…